Equine Hoof Stem Progenitor Cells (HPC) CD29 + /Nestin + /K15 + - a Novel Dermal/epidermal Stem Cell Population With a Potential Critical Role for Laminitis Treatment.
Authors: Marycz, Pielok, Kornicka-Garbowska
Journal: Stem cell reviews and reports
Summary
# Editorial Summary Laminitis remains one of equine medicine's most challenging conditions, yet the cellular mechanisms driving tissue destruction and repair remain poorly understood. Researchers isolated a previously uncharacterised stem cell population from the coronary corium—termed hoof progenitor cells (HPC)—and used flow cytometry, molecular analysis, and microscopy to establish their phenotypic profile and functional capacity. The cells expressed characteristic markers of dermal-epidermal progenitors (CD29+, Nestin+, K15+) alongside pluripotency factors (SOX2, OCT4, NANOG), demonstrated high proliferative rates in culture, and showed capacity for multilineage differentiation similar to mesenchymal stem cells. These findings suggest HPC may play a direct role in both laminitis pathogenesis and the natural recovery process, opening the possibility that therapeutic strategies targeting or enhancing this progenitor population could offer novel approaches to tissue restoration in affected horses. For practitioners managing laminitis cases, this work provides a foundation for understanding the biological basis of hoof healing and supports the future development of cell-based therapies alongside conventional farriery and veterinary management.
Read the full abstract on PubMed
Practical Takeaways
- •Research is identifying specific cell populations in the hoof that may drive tissue repair after laminitis-induced damage; this foundational work could eventually lead to targeted cell therapies for affected horses
- •Understanding hoof progenitor cell biology may help explain why some horses recover better from laminitis than others and inform future treatment strategies
- •This work is preliminary (in vitro characterization only) and not yet applicable to clinical practice, but represents an important step toward developing regenerative medicine approaches for laminitis
Key Findings
- •Novel hoof progenitor cells (HPC) isolated from equine coronary corium express stem cell markers CD29, nestin, K15, SOX2, OCT4, and NANOG
- •HPC demonstrate spindle-shaped morphology, eccentric nuclei, high proliferation rates, and multilineage differentiation potential similar to mesenchymal stem cells
- •HPC exhibit in vitro plasticity and expansion capacity suggesting potential direct involvement in laminitis pathogenesis and recovery
- •HPC identification may enable discovery of novel therapeutic targets and cell-based therapies for laminitis treatment